Local Injection of Aminoglycosides for Prophylaxis Against Infection in Open Fractures by Lawing, Cheryl Reese et al.
Local Injection of Aminoglycosides for Prophylaxis
Against Infection in Open Fractures
Cheryl Reese Lawing, MD, Feng-Chang Lin, PhD, and Laurence E. Dahners, MD
Investigation performed at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Background: The purpose of this study was to determine the efficacy of local wound cavity injections of aqueous amino-
glycosides (gentamicin and tobramycin), in conjunction with systemic antibiotics, to lower the prevalence of infection in
patients with open fractures.
Methods: Three hundred and fifty-one open fractures were identified by Current Procedural Terminology codes 11011
and 11012. Data on patient demographic characteristics, injury characteristics, infection, and fracture union were
obtained from the electronic medical records. Patients in the control group (183 fractures) received systemic antibiotics
only. Patients in the intervention group (168 fractures) received, in addition to systemic antibiotics, a locally administered
aminoglycoside (2 mg/mL) at the time of the index surgical procedure. At the discretion of the attending surgeon, some
wounds also received postoperative irrigations of aqueous aminoglycoside (n = 34). For wounds that could not be closed
and wounds that received postoperative irrigations, negative pressure dressings were used.
Results: The deep and superficial infection rate in the control group was 19.7% (thirty-six of 183 fractures), but it was
significantly lower (p = 0.010) in the intervention group at 9.5% (sixteen of 168 fractures). When comparing only the deep
infections, the infection rate in the control group was 14.2% (twenty-six of 183 fractures) compared with 6.0% (ten of 168
fractures) in the intervention group (p = 0.011). After multivariate analysis to adjust for possible confounding factors, the
administration of local antibiotics was found to be an independent predictor of lower infection rates in both deep and
superficial infections (odds ratio, 2.6 [95% confidence interval, 1.2 to 5.6]; p = 0.015) and deep infections only (odds
ratio, 3.0 [95% confidence interval, 1.1 to 8.5]; p = 0.034). The use of local antibiotics did not have an impact on nonunion
rate (p = 0.881), with a type-I error rate of a = 0.05 and 0.8 power.
Conclusions: This study suggests that local aqueous aminoglycoside administration as an adjunct to systemic antibi-
otics may be effective in lowering infection rates in open fractures; further research with higher-level research designs are
needed.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
O
pen fractures are known to be high risk for infection,
even when treated with thorough debridement, sta-
bilization, and appropriate systemic antibiotic therapy.
Infection rates can be divided on the basis of Gustilo-Anderson
fracture type1, although there is variation in the literature, with
rates of 0% to 6% for type-I fractures, rates of 2% to 6% for
type-II fractures, and rates of 5% to 50% for type-III frac-
tures2,3. Systemic antibiotics substantially lower infection rates
in open fractures4, but the continued high infection rates leave
room for improvement. Wound cavities are avascular; there-
fore, systemically administered antibiotics only achieve low
concentrations in the fluids that collect in the cavity (that may
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serve as culture media). In contrast, locally administered an-
tibiotics offer the potential to obtain high concentrations di-
rectly within the wound cavity while minimizing systemic
toxicity. Tobramycin-impregnated polymethylmethacrylate
beads have been demonstrated to significantly reduce infec-
tion in open fractures5-7. However, non-absorbable carriers
require a second surgical procedure for removal of the beads,
adding cost to the health-care system as well as additional
morbidity to the patient. Another option, locally adminis-
tered vancomycin powder, seems to have some efficacy in
lowering wound infection rates in the spine literature8,9, al-
though results are inconclusive10,11.
Promising animal studies have demonstrated the potential
for prophylaxis against infection with local injection of aqueous
gentamicin. Yarboro et al. demonstrated that local injection of
aqueous gentamicin was more effective in lowering wound bac-
terial counts than a sustained release device (calcium sulfate)12. A
subsequent study found that a combination of systemic cefazolin
and local gentamicin reduced wound bacterial counts by seven
orders of magnitude13, likely from the documented synergism
between cephalosporins and aminoglycosides14. Lovallo et al.
demonstrated decreased infection rates in patients undergoing
total shoulder arthroplasty and receiving intra-articular injection
of gentamicin15. One potential disadvantage of aqueous delivery
is that it does not fill dead space.
The most common organisms that infect open fracture
sites are gram-negative rods and gram-positive staphylococci2
and are mostly nosocomial16. Although aminoglycosides are
usually not first-line treatment for staphylococcal infections,
they can be used for this purpose16 because their bactericidal
activity is concentration-dependent and local administration
achieves high concentrations17.
Despite potential toxic effects with systemic aminoglyco-
sides, local administration has been documented to be safe. In
animal studies using local delivery of tobramycin via different
carriers, systemic levels are undetectable by twenty-four hours,
whereas levels within the wound cavity remain at high concen-
trations for around fourteen days18,19. Human studies have also
documented the safety of locally administered tobramycin with
calcium sulfate carriers20 and even prolonged administration
(mean, sixty-three days) via an implanted pump21.
Regarding local tissue toxicity, studies have shown no
histological impact on bone healing with tobramycin impreg-
nation of bone graft19. In vitro, Rathbone et al. found that high
local concentrations of gentamicin results in osteocyte toxicity,
whereas tobramycin does not22. However, there is a threshold
(200 mg/mL), after which high tobramycin levels decrease os-
teoblast replication23.
At our institution, locally administered antibiotics have been
used for years in a subset of patients, determined by the treating
surgeon. The purpose of this multisurgeon, single-institution,
retrospective cohort study was to evaluate the effect of locally
applied aqueous injections of aminoglycosides (gentamicin or
tobramycin), as an adjunct to systemic therapy, on the prevalence
of infection in patients with open fractures. We hypothesized that
locally injected aminoglycosides would result in lower infection
rates with no adverse effect on union rates, compared with
standard treatment with systemic antibiotics alone.
Materials and Methods
Following institutional review board approval, data were retrospectivelycollected from January 1, 2008, through August 31, 2013. During this pe-
riod, some patients with open fractures were treated with local antibiotics and
some were not, according to their attending surgeon’s preference. Patients with
open fractures were identified by a search for Current Procedural Terminology
(CPT) codes 11012 and 11011. Five hundred and twenty open fracture oper-
ative sites in 485 patients were identified. Fractures distal to the metacarpals
were excluded, as these fractures are frequently treated with irrigation and
debridement within the emergency department and patients are discharged
with oral antibiotics without formal operative intervention. Exclusion criteria
also included preexisting infection at the operative site, known major systemic
infection at the time of injury, operative fracture care delayed more than thirty-six
hours after injury, and patient age younger than ten years (juvenile patients). In
total, 169 fractures (33%) were excluded per Table I. This left 351 fractures, of
which 183 (52%) received systemic antibiotics alone and formed the control group.
One hundred and sixty-eight fractures (48%) received administration of local
antibiotics in addition to systemic antibiotics and formed the intervention group.
Data were collected from the institution’s electronic medical records.
Consult notes, inpatient progress notes, discharge summaries, operative re-
ports, telephone messages, and clinic notes were reviewed along with follow-up
clinic radiographs. Wound types were classified according to the Gustilo-
Anderson classification. Because of high interobserver variability, type was ret-
rospectively determined by a single senior-level resident, blinded to treatment
group, on the basis of preoperative and intraoperative descriptions of wounds,
amount of comminution on injury films, and descriptions of the necessary
debridement.
TABLE I Exclusions
Reason No. of Fractures
Phalanx fracture 57
Known prior infection 4




No open fracture* 18
Mandible fracture 3
Patient age younger than ten years 7
Locked chart 1
Antibiotic cement for bone loss 1
Mixed groups† 19





*This category includes open dislocation, traumatic amputation,
removal of vestigial tail, and debridement of surgical site infection
from another surgical procedure. †No local antibiotics were given
at the initial irrigation and debridement, but they were given at
subsequent fixation.‡This category includes death, amputation to
avoid reconstruction, amputation for necrosis without infection,
and no follow-up after initial discharge.
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TABLE II Comparison Between Groups*
Category Control Group (N = 183) Intervention Group (N = 168) P Value
Patient age† (yr) 36.9 ± 17.1 39.9 ± 17.0 0.096
Patient sex‡ 0.911
Female 64 (35.0) 57 (33.9)
Male 119 (65.0) 111 (66.1)
Tobacco use‡ 0.729
None or less than half a pack per day 142 (77.6) 136 (81.0)
One to one and a half packs per day 38 (20.8) 30 (17.9)
Two or more packs per day 3 (1.6) 2 (1.2)
Alcohol use‡ 0.915
None or occasional 101 (55.2) 91 (54.2)
Abuse 82 (44.8) 77 (45.8)
Illicit drug use‡ 0.541
No 134 (73.2) 128 (76.2)
Yes 49 (26.8) 40 (23.8)
Diabetes‡ 0.333
No 176 (96.2) 157 (93.5)
Yes 7 (3.8) 11 (6.5)
Polytrauma‡ 0.452
No 84 (45.9) 70 (41.7)
Yes 99 (54.1) 98 (58.3)
Intensive care unit admission‡ 0.232
No 102 (55.7) 105 (62.5)
Yes 81 (44.3) 63 (37.5)
ASA score† (points) 2.5 ± 1.0 2.5 ± 0.9 0.899
Fixation location‡ 0.847
Upper extremity 58 (31.7) 49 (29.2)
Lower extremity 63 (34.4) 58 (34.5)
Tibia 62 (33.9) 61 (36.3)
Fixation type‡ 0.015
Minimally invasive§ 82 (44.8) 54 (32.1)
Open reduction and internal fixation 53 (29.0) 72 (42.9)
Intramedullary nail 48 (26.2) 42 (25.0)
Time to surgical procedure† (hr) 11.6 ± 10.3 14.5 ± 10.7 <0.001#
Fracture type‡ 0.08
I 22 (12.0) 22 (13.1)
II 77 (42.1) 62 (36.9)
IIIA 55 (30.1) 68 (40.5)
IIIB 25 (13.7) 16 (9.5)
IIIC 4 (2.2) 0 (0.0)
Nonunions‡ 28 (15.3) 24 (14.3) 0.881
Duration of follow-up† (mo) 12.5 ± 12.5** 11.3 ± 11.1 0.278#
*The demographic, fracture, and fracture-healing characteristics of control and intervention groups are associations based on exposure to local
antibiotics.†The values are given as the mean and the standard deviation.‡The values are given as the number of fractures, with the percentage
in parentheses. §Minimally invasive fixation includes closed reduction percutaneous pinning and external fixation. #The p value was determined
with use of the Mann-Whitney test. **This value includes one patient who was lost to follow-up very quickly but had already developed an infection
and was therefore included.
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Both intervention and control groups received systemic antibiotics as
soon as possible according to standard of care. Per intervention protocol, all
patients received systemic intravenous antibiotic prophylaxis both preop-
eratively and postoperatively. This included 1 to 2 g of weight-based cefazolin
for type-I and II fractures or 600 mg of clindamycin if penicillin-allergic.
Weight-based gentamicin was added for type-III fractures and penicillin G
for barnyard-type contamination. The injection protocol for the interven-
tion group was established by the senior author. Gentamicin was used until
July 2011, at which point evidence for the inhibitory effect of gentamicin on
osteoblasts caused a change to use of tobramycin
22
. At the completion of the
irrigation and debridement and fixation procedure, 80 mg of aminoglycoside
diluted in 40 mL of normal saline (2 mg/mL) was injected by inserting the
needle down to bone and any implant after wound closure, so that the
injection filled the wound cavity. For lower types of Gustilo-Anderson
fractures, no further local antibiotic was administered. On the discretion of
the attending surgeon, in some patients with type-II and III fractures, a
catheter was placed within the wound and irrigations with a 0.5-mg/mL
mixture of aminoglycoside and normal saline were performed every six hours
for three to five days postoperatively. These wounds were dressed with a negative
pressure dressing.
Data collected included age, sex, location of injury, date of injury,
smoking status, alcohol use (abuse determined by presence of ethanol on trauma
screen or documentation of abuse in the alcohol and other drug consult note),
illicit drug use, presence of diabetes, presence of multitrauma (two or more long
bone injuries or two or more systems involved), American Society of Anesthe-
siologists (ASA) score, surgeon performing the procedure, time to surgical pro-
cedure, type of fixation, and duration to the time of the latest follow-up. The
primary outcome measure was the presence or absence of infection (excluding
pin-track infections), differentiated into deep and superficial infections, based
on Centers for Disease Control criteria
24
. Nonunion was indicated by recom-
mendation of bone-grafting or other surgical intervention for nonunion.
Statistical Analysis
Raw infection rate comparison was reported as the odds ratio between the
control group and the intervention group with use of the Fisher exact test for
significance. Analysis was further adjusted by confounding variables, which
were chosen on the basis of the associationwith outcome (infection) or primary
exposure (locally administered antibiotics). Chi-square test or t test was used
for the association, depending on the data type. Variables with a p value of £0.1
(tobacco use, alcohol use, diabetes, intensive care unit admission, ASA score,
fracture location, fixation type, time to surgical procedure, fracture type) were
included in the logistic regression model for the dichotomous infection out-
comes. The Mann-Whitney U test was used to analyze the impact of time to
surgical procedure.
Source of Funding
One author of this study (F.-C.L.) received a TraCS NIH CTSA grant
1UL1TR001111, which supported the statistical analysis.
Results
Demographic Characteristics
The demographic characteristics are shown in Table II. Nosignificant differences were detected in the comorbidities,
TABLE III Infection Rates
No Infection Deep Infection Deep and Superficial Infection
Control group (n = 183) 80.3% (147 fractures) 14.2% (26 fractures) 19.7% (36 fractures)
Intervention group (n = 168) 90.5% (152 fractures) 6.0% (10 fractures) 9.5% (16 fractures)
P value 0.011 0.010
TABLE IV Infection Pathogens and Resistance











Clostridium (not perfringens) 2
Enterococcus 1
No growth on culture 5
Control group
Polymicrobial 4
Serratia (ampicillin, ampicillin and
sulbactam)
1
Aeromonas (ampicillin and sulbactam) 1




and sulbactam, imipenem, tobramycin)
1
Enterococcus 2

























No growth on culture 10
*The antibiotic resistance appears in parentheses.
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(N = 36) P Value
Deep and Superficial
Infections (N = 52) P Value
Patient age† (yr) 38.3 ± 17.4 40.3 ± 14.9 0.497 38.8 ± 15.6 0.845
Patient sex‡ 0.189 1.00
Female 103 (34.4) 8 (22.2) 18 (34.6)
Male 196 (65.6) 28 (77.8) 34 (65.4)
Tobacco use‡ 0.001 0.011
None to less than half a pack per day 241 (80.6) 25 (69.4) 37 (71.2)
One to one and a half packs per day 56 (18.7) 8 (22.2) 12 (23.1)
Two or more packs per day 2 (0.7) 3 (8.3) 3 (5.8)
Alcohol use‡ 0.051 0.069
None or occasional 170 (56.9) 14 (38.9) 22 (42.3)
Abuse 129 (43.1) 22 (61.1) 30 (57.7)
Illicit drug use‡ 0.154 0.226
No 227 (75.9) 23 (63.9) 35 (67.3)
Yes 72 (24.1) 13 (36.1) 17 (32.7)
Diabetes‡ 0.096 0.162
No 286 (95.7) 32 (88.9) 47 (90.4)
Yes 13 (4.3) 4 (11.1) 5 (9.6)
Polytrauma‡ 0.597 0.88
No 132 (44.1) 14 (38.9) 22 (42.3)
Yes 167 (55.9) 22 (61.1) 30 (57.7)
Intensive care unit admission‡ 0.074 0.171
No 181 (60.5) 16 (44.4) 26 (50.0)
Yes 118 (39.5) 20 (55.6) 26 (50.0)
ASA score† (points) 2.5 ± 1.0 2.8 ± 1.0 0.093 2.5 ± 0.9 0.095
Fixation location 0.104 0.084
Upper extremity 96 (32.1) 10 (27.8) 11 (21.2)
Lower extremity 105 (35.1) 8 (22.2) 16 (30.8)
Tibia 98 (32.8) 18 (50.0) 25 (48.1)
Fixation type‡ 0.004 0.023
Minimally invasive§ 107 (35.8) 23 (63.9) 29 (55.8)
Open reduction and internal fixation 111 (37.1) 6 (16.7) 14 (26.9)
Intramedullary nail 81 (27.1) 7 (19.4) 9 (17.3)
Time to surgical procedure† (hr) 13.5 ± 10.9 10.7 ± 8.4 0.122# 10.3 ± 8.0 0.023#
Fracture type‡ <0.001 <0.001
I 42 (14.0) 2 (5.6) 2 (3.8)
II 122 (40.8) 7 (19.4) 17 (32.7)
IIIA 108 (36.1) 10 (27.8) 15 (28.8)
IIIB 25 (8.4) 15 (41.7) 16 (30.8)
IIIC 2 (0.7) 2 (5.6) 2 (3.8)
Nonunions‡ 32 (10.7) 18 (50.0) <0.001 20 (38.5) <0.001
Duration of follow-up† (mo) 11.3 ± 11.2 16.3 ± 15.6 0.04# 15.4 ± 14.6 0.034#
*The demographic and fracture characteristics are based on presence or absence of infection (i.e., associations based on outcomes). †The
values are given as the mean and the standard deviation. ‡The values are given as the number of fractures, with the percentage in parentheses.
§This fixation includes closed reduction percutaneous pinning and external fixation. #These p values were determined with use of the
Mann-Whitney test.
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fracture characteristics (type and location), and duration of
follow-up between the intervention group and the control
group (Table II), except for fixation type (p = 0.015) and time
to surgical procedure (p < 0.001). There was a higher rate of open
reduction and internal fixation compared withminimally invasive
treatment (including closed reduction percutaneous pinning and
external fixation) in the intervention group (42.9%) compared
with the control group (29.0%). The mean time to surgical pro-
cedure was longer in the intervention group (14.5 ± 10.7 hours)
compared with the control group (11.6 ± 10.3 hours).
Infection Rates
For deep and superficial infections, the infection rate in the
control group was 19.7% (thirty-six of 183 fractures). The deep
and superficial infection rate in the intervention group was sig-
nificantly lower (p = 0.010) at 9.5% (sixteen of 168 fractures).
For deep infections alone, the control group had an infection rate
of 14.2% (twenty-six of 183 fractures), compared with the in-
tervention group’s deep infection rate of 6.0% (ten of 168 frac-
tures), which was significant at p = 0.011. Table III summarizes
infection rates. Table IV shows the breakdown of pathogens and
antibiotic resistances on specimens taken for culture.
Factors Impacting Infection
Compared with the mean time to surgical procedure (13.5 ±
10.9 hours) for the patients without infection, the mean time
to surgical procedure in patients with deep infection was not
significantly different (p = 0.122) at 10.7 ± 8.4 hours, but in the
group of patients with combined deep and superficial infection,
it was significantly shorter (p = 0.023) at 10.3 ± 8.0 hours.
Tobacco use and type of fixation had significant impact (p <
0.05) on infection rates, as demonstrated in Table V. There was
a significantly higher rate of infection in patients undergoing
closed reduction percutaneous pinning and external fixation
(p = 0.004 for deep infections and p = 0.023 for deep and
superficial infections).
Multivariate Analysis
Multivariate analysis was performed to adjust for potential
differences between the intervention group and the control
group. Alcohol, diabetes, intensive care unit admission, ASA
score, fracture location, time to surgical procedure, fixation,
fracture type, and tobacco use were also deemed potential
confounding variables with p values of <0.1, and so were also
adjusted for in the multivariate analysis (Table VI). Results
were similar between the adjusted and unadjusted odds ratios
for deep and superficial infection with an unadjusted odds ratio
of 2.5 (95% confidence interval [95% CI], 1.2 to 4.9; p = 0.010)
and an adjusted odds ratio of 2.6 (95% CI, 1.2 to 5.6; p =
0.015). This was similar for deep infections only, with an un-
adjusted odds ratio of 2.7 (95% CI, 1.3 to 5.8; p = 0.011) and an
adjusted odds ratio of 3.0 (95% CI, 1.1 to 8.5; p = 0.034).
Nonunion Rates
Exposure to local antibiotics (Table II) did not have a signifi-
cant impact on nonunion rates (p = 0.881). With at least 160
patients in each group, we could detect a difference (based on a
15% nonunion rate in the patients in the control group and a
5% nonunion rate in the patients in the intervention group)
with a type-I error rate of a = 0.05 and 0.8 power.
Discussion
This study found that locally administered antibiotics intoopen fracture wound cavities independently lowered in-
fection rates. The deep infection rate in the intervention group
(6.0%) was significantly lower (p = 0.011) than in the control
group (14.2%). Likewise, the deep and superficial infection rate
in the intervention group (9.5%) was significantly lower (p =
0.010) than that in the control group (19.7%). There is sub-
stantial variability of infection rates reported in the literature,
from 4% to 63% in one systematic review25 and 11% to 25% in
other studies26-28. Given this variability, the current study had
the advantage of using a control group of concomitantly treated
patients within the same institution with similar demographic
and fracture characteristics. This supports the significance of
the lowered infection rates of the intervention group.
This study supports the findings of other studies doc-
umenting the efficacy of locally administered antibiotics5,6,8,9.
The injection protocol used in this study has the advantage of
not requiring a secondary surgical procedure to remove an-
tibiotic beads and uses the previously documented efficacy of
an aqueous form of delivery12 and the documented synergism
between aminoglycosides and cephalosporins13,14. For thirty-
four of the more severe injuries, aqueous aminoglycosides
were used for postoperative irrigations. This subset of patients
did not have a difference in infection rates (15% for deep and
superficial infections and 8% for deep infections; p = 0.324)
compared with the patients receiving only a single dose of
local antibiotic (12% for deep and superficial infections and
5% for deep infections; p = 0.123). The similar infection rates
suggest, but do not prove, that postoperative irrigations may
be effective in severe wounds and that we were able to effec-
tively identify which patients might benefit from augmented
treatment.
An additional advantage of using aminoglycosides rather
than vancomycin powder, as the spine literature suggests8,9, is
that it allows vancomycin be reserved for therapeutic, rather
TABLE VI Multivariate Analysis
Analysis Odds Ratio* P Value
Unadjusted (deep infections) 2.7 (1.3 to 5.8) 0.011
Adjusted (deep infections) 3.0 (1.1 to 8.5) 0.034
Unadjusted (deep and
superficial infections)
2.5 (1.2 to 4.9) 0.010
Adjusted (deep and superficial
infections)
2.6 (1.2 to 5.6) 0.015
*The values are given as the odds ratio, with the 95% CI in
parentheses.
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than prophylactic, purposes. Historically, drug resistance has
paralleled increasing antibiotic usage29-31. Thus, there is concern
that increased use of vancomycin for prophylaxis could con-
tribute to development of vancomycin-resistant organisms32,33.
There was a significantly higher rate (p = 0.015) of open
reduction and internal fixation at the index surgical procedure
in the intervention group (42.9%) compared with the control
group (29.0%). Although there was a trend toward lower in-
fection rates in the intervention group of patients undergoing
open reduction and internal fixation (4.4% compared with
6.1% for deep infection and 9.7% compared with 13.2% for
deep and superficial infection), this did not reach significance
(p = 0.694 for deep infection and p = 0.576 for deep and
superficial infection). However, the low number of patients in
this subset (fifty-three in the control group and seventy-two in
the intervention group) means that this subset study was un-
derpowered to detect a difference. Subset analysis showed that
patients undergoing minimally invasive fixation had higher-
grade fracture types and intensive care unit admission rates.
However, there was no difference in the overall fracture type,
comorbidities, or intensive care unit admission rates between
the intervention group and the control group. We suspect
that surgeons utilizing locally administered antibiotics became
more confident in their ability to immediately perform open
reduction and internal fixation, rather than temporizing with
external fixation. The potential for higher rates of infection
with more surgical dissection in the patients undergoing open
reduction and internal fixation must be countered with the
realization that improved stability with open reduction and
internal fixation may lower infection rates. Although we at-
tribute the lower infection rates to the locally administered
antibiotics, this emphasizes the need for a randomized pro-
spective study that also controls for the protocol by which
to select patients for administration of postoperative local
antibiotics.
There were significantly longer mean times to the sur-
gical procedure in the intervention group (14.5 hours) com-
pared with the control group (11.6 hours), which may be due
to a decreased sense of urgency for emergent debridement in
surgeons using local antibiotics. A higher rate of infection was
associated with a shorter mean time to surgical procedure for
patients with infection (10.3 hours) compared with patients
with no infection (13.5 hours), although this might be due to
differential local antibiotic utilization in these patients.
Locally administered antibiotics were not associated with
a difference in the nonunion rate (p = 0.881, type-I error rate
a = 0.05, 0.8 power). However, some studies suggest that
higher levels of aminoglycosides, especially gentamicin, cause
osteocyte toxicity 22,23. Antibiotic levels within the wound cavity,
duration, and potential local toxicity were not directly assessed
in this study. The nonunion rates were similar in the two
groups (15.3% in the control group compared with 14.3% in
the intervention group); however, this study only had the
power to detect a difference of 15% nonunion compared with
5%, so we cannot rule out a small difference. Furthermore,
there is inherent variability in the determination of the nonunion
end point by a decision for further treatment. Further study
with more objective prospective criteria is needed to conclu-
sively determine whether there is a negative impact on osseous
healing.
This study was limited by its retrospective nature. Pa-
tients were “surgeon randomized” in that the decisions of the
treating surgeons determined inclusion into the intervention
group compared with the control group. Thus, there is the
potential that differences in surgeon debridement techniques
or fixation choices contributed to the different infection rates,
especially given that the senior author contributed 46% of the
patients in the intervention group. There were thirteen surgeons
who only intermittently used the injection protocol, contribut-
ing patients to both groups. They may have been more likely to
use local antibiotic therapy in more severe injuries, which could
have resulted in higher infection rates in the intervention group
than would otherwise be expected.
Tominimize poor interobserver agreement with Gustilo-
Anderson classification34, all injuries were classified by a single
senior orthopaedic resident blinded to treatment group. How-
ever, despite attempts to consistently stratify patients, observer
variability makes it possible that fractures in this study would be
classified differently by others. Hence, infection rates as a func-
tion of Gustilo-Anderson classification in this study may not be
comparable with other reports.
This study concurs with basic scientific studies12,13
demonstrating the efficacy of local aqueous aminoglycoside
administration as an adjunct to systemic antibiotics in low-
ering infection rates. The intervention group receiving locally
administered aminoglycosides, by our protocol, demonstrated a
significantly reduced infection rate compared with the control
group receiving systemic antibiotics alone. Although this study
was limited by its retrospective nature and the confounding
variable of surgeon experience or technique impacting results, we
hope that it will provide support for future prospective, blinded,
and randomized trials comparing locally injected aqueous ami-
noglycosides to both systemic antibiotics alone as well as other
forms of local antibiotic delivery. n
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